Xtl Biopharmaceuticals Stock Forecast

Buy or Hold candidate since Jul 02, 2026 Gain 7.78%

The XTL Biopharmaceuticals Ltd. stock price gained 0.692% on the last trading day (Friday, 10th Jul 2026), rising from $2.89 to $2.91. During the last trading day the stock fluctuated 11.07% from a day low at $2.62 to a day high of $2.91. The price has fallen in 5 of the last 10 days but is still up by 13.23% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 10 thousand more shares were traded than the day before. In total, 16 thousand shares were bought and sold for approximately $45.74 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -3.27% during the next 3 months and, with a 90% probability hold a price between $1.95 and $3.67 at the end of this 3-month period.

XTLB Signals & Forecast

The XTL Biopharmaceuticals Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.86 and $2.51. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). XTL Biopharmaceuticals Ltd. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. The very low volume increases the risk and reduces the other technical signals issued. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Monday, July 06, 2026, and so far it has fallen -7.32%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.73 and $2.61. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, XTL Biopharmaceuticals Ltd. finds support just below today's level at $2.73. If this is broken, then the next support from accumulated volume will be at $2.61 and $2.49.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.290 between high and low, or 11.07%. For the last week, the stock has had daily average volatility of 13.76%.

Our recommended stop-loss: $2.74 (-5.84%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 4 days ago.)

Trading Expectations (XTLB) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect XTL Biopharmaceuticals Ltd. to open at $2.81, and during the day (based on 14 day Average True Range), to move between $2.75 and $3.07, which gives a possible trading interval of +/-$0.314 (+/-11.41%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 11.41% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.73 (6.19%) than the resistance at $3.14 (7.90%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is XTL Biopharmaceuticals Ltd. stock A Buy?

XTL Biopharmaceuticals Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold candidate.

Current score: 0.315 Hold/Accumulate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $2.81 ( 3.32%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk